Elation Health, Surescripts Partner to Boost Medication Affordability

What You Should Know:

Elation Health, a provider of clinical-first technology for primary care, has announced a major expansion of its partnership with Surescripts, the nation’s leading health information network.

– This collaboration brings Surescripts Real-Time Prescription Benefit directly into Elation’s EHR, empowering clinicians with real-time medication cost and coverage information for their patients.

Medication Affordability at the Point-of-Care

Medication affordability is a major hurdle for patients: High costs can lead to medication abandonment, negatively impacting treatment adherence and health outcomes. Real-time information at the point of care is key: Equipping clinicians with instant access to patient-specific coverage and cost data at the time of prescribing fosters informed conversations and empowers patients to make better choices.

Benefits for Patients and Providers

Surescripts real-time prescription benefit on Elation’s EHR offers:

  • On-Demand Formulary: Seamless access to patient-specific coverage benefits and cost data for all medications.
  • Enhanced Decision-Making: Information on prior authorization requirements, lower-cost alternatives, and out-of-pocket estimates.
  • Improved Patient Engagement: Transparency leads to a better understanding of costs and increased medication adherence.
  • Reduced Administrative Burden: Eliminates time spent chasing pharmacy benefits information.

The Elation EHR is specifically designed for primary care, with intuitive charting and seamless interoperability to enhance the clinical experience. The platform is used by a diverse range of healthcare providers, from independent practices to large enterprise networks.

“Together, we’re removing barriers to medication access and empowering providers to deliver less costly, more effective care,” said Dr. Andrew Mellin, Surescripts Chief Medical Information Officer.

Just Like Last Year

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

Read More »